Impressum
Campus Berlin-Buch GmbH
Robert-Rössle-Straße 10
D-13125 Berlin
Fax: 030-94 89 38 12
E-Mail: info@campusberlinbuch.de
Managing Directors:
Dr. Christina Quensel, Dr. Ulrich Scheller
Court of Registry: Charlottenburg (Berlin) District Court
Commercial Register Number: HRB 57456
Editorial responsibility: Responsible according to German law: Christine Minkewitz (address as listed above)
Disclaimer of liability: The information of this website was compiled with utmost care. Despite meticulous checks, we assume no liability for the content of external links. The operators of the linked websites are solely responsible for their content.
Sponsors
This website is supported by:
Akademie der Gesundheit Berlin/Brandenburg e.V.
Charité - Universitätsmedizin Berlin
Eckert & Ziegler AG
Erste Wohnungsgenossenschaft Berlin-Pankow eG
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)
Ludwig Hoffmann Quartier
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Vattenfall Wärme Berlin AG
Further sponsors are:
Autohaus Golbeck
Photos:
Thomas Oberländer, Peter Himsel, Ralf Grömminger, Jürgen Dachner, Schütte, Matthies, Lösch, Hugel, MDC, Berlin-Buch Management GmbH - Regionalmanagement, David Ausserhofer, Christine Minkewitz, EPO GmbH, HOWOGE, Campus Berlin-Buch GmbH, Akademie der Gesundheits Berlin-Brandenburg e.V.
Imagefilm:
MYP Media
News Buch Berlin
Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply
Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today a...
more ...Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) announces that the spin-off resolution approved at the Annual General Meeting on 26 June 2024 was entered in the commercial register of the Charlottenbu...
more ...OMEICOS Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease
Interim data confirms OMT-28's strong safety profile in PMD patients, top-line data expected mid-2025
more ...Events Buch Berlin
05.11.2024, 16:00
Die Zukunft der Hirnkrebstherapie: Fortschritte, Herausforderungen und Visionen
Vortrag in der Reihe: Neue Wege in der Biomedizin - Aktuelle Forschungsthemen des Campus Berlin-Buch
more ...06.11.2024, 13:30
Einladung zur Vorlesung: "Rätselhafte Gehirne - Ursachen von Demenz bei Jung und Alt"
in der Reihe "Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch"
more ...11.11.2024, 09:00
Fachkraft für Molekularbiologie
Das 11-tägige Intensiv-Seminar vermittelt Grundlagenwissen zu den wichtigsten Labormethoden der modernen Molekularbiologie und vermittelt Einblicke in die klinische Forschung.
more ...
